As of May 21, 92 confirmed cases and 28 suspected cases of monkeypox have been reported in 12 non monkeypox endemic countries. Who predicts that the global monkeypox cases may increase further. Recently, Bavarian Nordic Bava, a pharmaceutical company headquartered in Copenhagen, Denmark, said that it had signed a supply contract for smallpox vaccine imvanex with an unnamed European country to deal with the monkeypox epidemic.
According to the Centers for Disease Control and Prevention (CDC), monkeypox is a disease caused by a virus belonging to the same family as smallpox, but it is not as serious as smallpox. According to the observation and research of the World Health Organization and CDC in Africa, the effectiveness of smallpox vaccine in preventing monkeypox is 85%. The agency believes that preparations should be made in advance to strengthen the monitoring of cases with similar symptoms and develop diagnostic methods and reagents, so as to find imported cases in time, block the transmission and prevent the prevalence of monkeypox in China.
According to the theme database of financial Associated Press, among the relevant listed companies:
Beijing Tiantan Biological Products Corporation Limited(600161) is the largest vaccine manufacturer in China. It has pilot and clinical research projects of new smallpox vaccine.
Beijing Konruns Pharmaceutical Co.Ltd(603590) is the only cooperative company of Bavarian Nordic in China and parts of Asia. Bavarian Nordic is a long-term supplier of non replicative smallpox vaccine of the U.S. government. The vaccine has been approved by the U.S. Food and Drug Administration and can also be used to prevent monkeypox.
